|
1
|
Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis.
|
Arthritis Rheum
|
1999
|
1.50
|
|
2
|
Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404.
|
Eur J Pharmacol
|
2000
|
1.21
|
|
3
|
Antiinflammatory and immunoregulatory action of methotrexate in the treatment of rheumatoid arthritis: evidence of increased interleukin-4 and interleukin-10 gene expression demonstrated in vitro by competitive reverse transcriptase-polymerase chain reaction.
|
Arthritis Rheum
|
1998
|
1.08
|
|
4
|
Human collagen II peptide 256-271 preferentially binds to HLA-DR molecules associated with susceptibility to rheumatoid arthritis.
|
Immunogenetics
|
1999
|
0.92
|
|
5
|
A role for the endogenous cannabinoid system in the peripheral control of pain initiation.
|
Prog Brain Res
|
2000
|
0.84
|